| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.71B | +6.2% |
| Cost of Revenue | $2.12B | +5.9% |
| Gross Profit | $2.59B | +6.4% |
| R&D Expense | $368.0M | +7.0% |
| SG&A Expense | $1.43B | +8.8% |
| Pre-tax Income | -$224.0M | -145.9% |
| Income Tax | $8.0M | -94.7% |
| Net Income | -$232.0M | -168.6% |
| EPS (Basic) | -$0.47 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $545.0M | +16.5% |
| Accounts Receivable | $873.0M | +8.4% |
| Inventory | $1.74B | +10.4% |
| Current Assets | $3.46B | +7.6% |
| Total Assets | $13.36B | +5.9% |
| Current Liabilities | $1.60B | +21.4% |
| Long-term Debt | $3.76B | -12.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $560.0M | +3.5% |
| Capital Expenditures | $276.0M | +87.8% |
| Investing Cash Flow | -$279.0M | -124.1% |
| Financing Cash Flow | -$275.0M | +81.6% |
| Free Cash Flow | $284.0M | -27.9% |
| -169.1% |
| EPS (Diluted) | -$0.47 | -169.1% |
| Total Liabilities |
| $6.81B |
| +4.5% |
| Stockholders' Equity | $6.55B | +7.4% |